Proteomic profiling of retinoblastoma by high resolution mass spectrometry

[1]  Wei Zhang,et al.  Cellular Retinoic Acid-binding Protein 2 Inhibits Tumor Growth by Two Distinct Mechanisms* , 2014, The Journal of Biological Chemistry.

[2]  P. Schirmacher,et al.  Insulin‐like growth factor 2 mRNA‐binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma , 2014, Hepatology.

[3]  R. Korneluk,et al.  IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1 , 2014, Oncogene.

[4]  A. Schulze,et al.  Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development , 2013, Disease Models & Mechanisms.

[5]  A. von Kriegsheim,et al.  RCP-driven α5β1 recycling suppresses Rac and promotes RhoA activity via the RacGAP1–IQGAP1 complex , 2013, The Journal of cell biology.

[6]  Jiong Chen,et al.  Profiling the potential tumor markers of pancreatic ductal adenocarcinoma using 2D-DIGE and MALDI-TOF-MS: up-regulation of Complement C3 and alpha-2-HS-glycoprotein. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[7]  Shi-ting Li,et al.  Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression , 2013, Journal of Neuro-Oncology.

[8]  Johannes Griss,et al.  The Proteomics Identifications (PRIDE) database and associated tools: status in 2013 , 2012, Nucleic Acids Res..

[9]  Stefan Hüttelmaier,et al.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? , 2012, Cellular and Molecular Life Sciences.

[10]  S. Pratap,et al.  Fetuin‐A triggers the secretion of a novel set of exosomes in detached tumor cells that mediate their adhesion and spreading , 2012, FEBS letters.

[11]  K. Sakamoto,et al.  Midkine in the pathology of cancer, neural disease, and inflammation , 2012, Pathology international.

[12]  Matthew W. Wilson,et al.  A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses , 2011, Nature.

[13]  I. Modlin,et al.  The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors. , 2011, Endocrinology and metabolism clinics of North America.

[14]  J. Ochieng,et al.  Fetuin-A (α2HS-Glycoprotein) Is a Major Serum Adhesive Protein That Mediates Growth Signaling in Breast Tumor Cells* , 2010, The Journal of Biological Chemistry.

[15]  C. Shields,et al.  Differential gene expression profile of retinoblastoma compared to normal retina , 2010, Molecular vision.

[16]  P. R. Deepa,et al.  Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors , 2010, Proteomics. Clinical applications.

[17]  J. Ochieng,et al.  Cystatin Superfamily , 2010, Journal of health care for the poor and underserved.

[18]  Min-Seok Kwon,et al.  Quantitative analysis of phosphopeptides in search of the disease biomarker from the hepatocellular carcinoma specimen , 2009, Proteomics.

[19]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[20]  M. Gleave,et al.  Effects of Eg5 knockdown on human prostate cancer xenograft growth and chemosensitivity , 2008, The Prostate.

[21]  S. Hauptmann,et al.  Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma , 2007, Oncogene.

[22]  K. Helle,et al.  The endocrine role for chromogranin A: A prohormone for peptides with regulatory properties , 2007, Cellular and Molecular Life Sciences.

[23]  Kai A. Reidegeld,et al.  Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research , 2007, Proteomics.

[24]  E. Knudsen,et al.  Role of the retinoblastoma tumor suppressor in the maintenance of genome integrity. , 2006, Current molecular medicine.

[25]  A. Giordano,et al.  pRb2/p130: a new candidate for retinoblastoma tumor formation , 2006, Oncogene.

[26]  Guanghui Wang,et al.  Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. , 2006, Journal of Proteome Research.

[27]  L. Matrisian,et al.  The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms. , 2005, Cancer research.

[28]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[29]  Amy P N Skubitz,et al.  Differential gene expression in ovarian carcinoma: identification of potential biomarkers. , 2004, The American journal of pathology.

[30]  A. Villa,et al.  Chromogranin A protects vessels against tumor necrosis factor α‐induced vascular leakage , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  T. Muramatsu,et al.  Midkine and pleiotrophin in neural development and cancer. , 2004, Cancer letters.

[32]  T. Kitamura,et al.  MgcRacGAP regulates cortical activity through RhoA during cytokinesis. , 2004, Experimental cell research.

[33]  W. Jahnen-Dechent,et al.  Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. , 2003, The Biochemical journal.

[34]  A. Nakagawara,et al.  A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. , 1993, Cancer research.

[35]  W. Müller-Esterl,et al.  The nucleotide and deduced amino acid structures of sheep and pig fetuin. Common structural features of the mammalian fetuin family. , 1992, European journal of biochemistry.

[36]  T. Muramatsu,et al.  Structure of a retinoic acid-responsive gene, MK, which is transiently activated during the differentiation of embryonal carcinoma cells and the mid-gestation period of mouse embryogenesis. , 1990, The Journal of biological chemistry.

[37]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[38]  D. Comings.  A general theory of carcinogenesis. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Smeitink,et al.  Pharmacological targeting of mitochondrial complex I deficiency: the cellular level and beyond. , 2012, Mitochondrion.

[40]  O. Louthan.  Chromogranin a in physiology and oncology. , 2011, Folia biologica.

[41]  J. C. Tony.  The chromogranin-secretogranin family. , 2003, The New England journal of medicine.

[42]  F. Bertucci,et al.  Gene expression profiling of primary breast carcinomas using arrays of candidate genes. , 2000, Human molecular genetics.

[43]  D. Crowe,et al.  Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion. , 1998, Anticancer research.

[44]  J. Bohl,et al.  Amyloid-related neuropathies. , 1990, Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie.